These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25072779)

  • 1. Pregabalin serum levels in apprehended drivers.
    Kriikku P; Wilhelm L; Rintatalo J; Hurme J; Kramer J; Ojanperä I
    Forensic Sci Int; 2014 Oct; 243():112-6. PubMed ID: 25072779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations.
    Kriikku P; Wilhelm L; Rintatalo J; Hurme J; Kramer J; Ojanperä I
    Forensic Sci Int; 2012 Jul; 220(1-3):111-7. PubMed ID: 22391477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and blood concentrations of desoxypipradrol (2-DPMP) in drivers suspected of driving under the influence of drugs and in post-mortem cases.
    Kriikku P; Wilhelm L; Rintatalo J; Hurme J; Kramer J; Ojanperä I
    Forensic Sci Int; 2013 Mar; 226(1-3):146-51. PubMed ID: 23333504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland.
    Kriikku P; Wilhelm L; Schwarz O; Rintatalo J
    Forensic Sci Int; 2011 Jul; 210(1-3):195-200. PubMed ID: 21477955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedative-hypnotics are widely abused by drivers apprehended for driving under the influence of drugs.
    Kriikku P; Hurme H; Wilhelm L; Rintatalo J; Hurme J; Kramer J; Ojanperä I
    Ther Drug Monit; 2015 Jun; 37(3):339-46. PubMed ID: 25254415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiles of pregabalin and gabapentin abuse by postmortem toxicology.
    Häkkinen M; Vuori E; Kalso E; Gergov M; Ojanperä I
    Forensic Sci Int; 2014 Aug; 241():1-6. PubMed ID: 24835028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychoactive substances in seriously injured drivers in Denmark.
    Wiese Simonsen K; Steentoft A; Bernhoft IM; Hels T; Rasmussen BS; Linnet K
    Forensic Sci Int; 2013 Jan; 224(1-3):44-50. PubMed ID: 23142064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis findings in drivers suspected of driving under the influence of drugs in Finland from 2006 to 2008.
    Blencowe T; Pehrsson A; Mykkänen S; Gunnar T; Lillsunde P
    Forensic Sci Int; 2012 Apr; 217(1-3):107-12. PubMed ID: 22024655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age- and gender-related differences in blood amphetamine concentrations in apprehended drivers: lack of association with clinical evidence of impairment.
    Jones AW
    Addiction; 2007 Jul; 102(7):1085-91. PubMed ID: 17498183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.
    Raikos N; Schmid H; Nussbaumer S; Ambach L; Lanz S; Längin A; König S; Roth N; Auwärter V; Weinmann W
    Forensic Sci Int; 2014 Oct; 243():130-6. PubMed ID: 25173986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First nationwide study on driving under the influence of drugs in Switzerland.
    Senna MC; Augsburger M; Aebi B; Briellmann TA; Donzé N; Dubugnon JL; Iten PX; Staub C; Sturm W; Sutter K
    Forensic Sci Int; 2010 May; 198(1-3):11-6. PubMed ID: 20211534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
    Jones AW; Holmgren A; Kugelberg FC
    Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009).
    Gjerde H; Christophersen AS; Normann PT; Assum T; Oiestad EL; Mørland J
    Traffic Inj Prev; 2013; 14(5):443-52. PubMed ID: 23697895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
    Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
    Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregabalin--a drug with abuse potential?].
    Skopp G; Zimmer G
    Arch Kriminol; 2012; 229(1-2):44-54. PubMed ID: 22448469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of psychoactive substances in oral fluid from randomly selected drivers in Denmark.
    Simonsen KW; Steentoft A; Hels T; Bernhoft IM; Rasmussen BS; Linnet K
    Forensic Sci Int; 2012 Sep; 221(1-3):33-8. PubMed ID: 22554868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A field test of substance use screening devices as part of routine drunk-driving spot detection operating procedures in South Africa.
    Matzopoulos R; Lasarow A; Bowman B
    Accid Anal Prev; 2013 Oct; 59():118-24. PubMed ID: 23770390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality among subjects previously apprehended for driving under the influence of traffic-hazardous medicinal drugs.
    Hausken AM; Skurtveit S; Christophersen AS
    Drug Alcohol Depend; 2005 Sep; 79(3):423-9. PubMed ID: 16102382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of a drunk driver and risk factors for drunk driving. Findings in roadside testing in the province of Uusimaa in Finland 1990-2008.
    Portman M; Penttilä A; Haukka J; Rajalin S; Eriksson CJ; Gunnar T; Koskimaa H; Kuoppasalmi K
    Forensic Sci Int; 2013 Sep; 231(1-3):20-7. PubMed ID: 23890612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs.
    Wille SM; Raes E; Lillsunde P; Gunnar T; Laloup M; Samyn N; Christophersen AS; Moeller MR; Hammer KP; Verstraete AG
    Ther Drug Monit; 2009 Aug; 31(4):511-9. PubMed ID: 19571773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.